Real-time enrollment status for this non-small cell lung cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 7:18 AM UTC
| NCT Number | NCT04613596 |
| Recruiting Status | Recruiting |
| Condition | Non-small cell lung cancer |
| Phase | Clinical Trial |
| Target Enrollment | 806 participants |
| Active Locations | 219 sites in the US |
| Sponsor | Mirati Therapeutics Inc. |
| Last Updated on CT.gov | February 13, 2026 (2 weeks ago) |
As of March 2, 2026: Clinical trial NCT04613596 is currently recruiting participants. This clinical trial study for non-small cell lung cancer is actively seeking new participants at 219 locations across the United States. The study is sponsored by Mirati Therapeutics Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04613596 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 219 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04613596 was last updated 2 weeks ago (February 13, 2026). HelloStudys verifies this status automatically.